Linda Palczuk

Affiliations

  • Director at Avadel Pharmaceuticals Plc (AVDL), 2025-01-28
  • Chief Operating Officer at Verrica Pharmaceuticals Inc. (VRCA), 2019-03-04
  • President & Ceo at Osiris Therapeutics Inc. (OSIR), 2017-09-21
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
AVDL $7.93 5,000 $39,640.00 67,900 2025-01-21 Filing
AVDL $10.19 3,000 $30,567.60 66,400 2024-12-06 Filing
AVDL $14.76 2,500 $36,900.00 52,400 2023-05-09 Filing
AVDL $7.20 2,000 $14,405.00 49,900 2022-12-23 Filing
AVDL $1.60 10,000 $16,000.00 47,900 2022-05-27 Filing